NAD+
Studied for: cellular energy
NAD+ is a coenzyme central to how cells convert fuel into usable energy. Research examines its role in redox reactions, mitochondrial output, and the repair pathways associated with biological aging.
Last reviewed September 26, 2026
How it is thought to work
NAD+ acts as an electron carrier in the reactions that release energy from nutrients. It is also a required substrate for sirtuins, enzymes studied for metabolic regulation and cellular maintenance.
- Redox CarrierCycles between oxidized and reduced forms to shuttle electrons through the reactions generating cellular energy.
- Sirtuin SubstrateConsumed by sirtuin enzymes, linking NAD+ availability to signaling around mitochondrial upkeep and stress response.
- Route studied
- Subcutaneous
- Research status
- Early clinical
NAD+ biology is well characterized in reviews and animal work, and small randomized human trials have examined NAD+-boosting precursors such as NMN, while controlled human data on subcutaneous NAD+ itself remain limited.
Research
What the research covers
What research examines
- Cellular energy metabolism and redox reactions
- Sirtuin activity in aging and disease
- Aging-related metabolic decline and neurodegeneration
- Blood-brain barrier integrity in aging animal models
- Muscle insulin sensitivity in human trials of the precursor NMN
Reported effects in studies
- Human safety data for subcutaneous NAD+ are limited
- Safety of the precursor NMN has been reviewed across human clinical trials
- A review has raised safety questions about NMN marketed as an anti-aging product
- Adverse events for NAD+ itself are not summarized in the cited studies
Studied range
What research protocols have used
Research protocols have used 50–200 mg per administration, 3 times per week (morning). Reported cycle: continuous.
For research use only. These figures summarize published research protocols. They are not instructions or medical advice.
Every CoreX order ships with a per-lot protocol guide.
Open the reconstitution calculatorRelated compounds
Researched alongside
- SS-31SS-31, also known as elamipretide, is studied for its affinity for the inner mitochondrial membrane. Research focuses on cardiolipin, a phospholipid central to mitochondrial efficiency.Read profile$329
- MOTS-cMOTS-c is a peptide encoded in mitochondrial DNA. Research examines its role as a signal between the mitochondria and the nucleus, particularly under metabolic stress.Read profile$99
- SLU-PP-332SLU-PP-332 is studied as an agonist of estrogen-related receptors, a family associated with the metabolic adaptations that follow endurance exercise.Read profile
- GLP-3RGLP-3R is studied as a triple agonist at the GLP-1, GIP, and glucagon receptors. Research examines whether engaging all three affects metabolic regulation differently to dual or single agonists.Read profile$119
Studies
Cited research
- NAD+ and sirtuins in aging and disease.
Trends in cell biology · 2014 · Review · PMID 24786309
- NAD⁺ in aging, metabolism, and neurodegeneration.
Science (New York, N.Y.) · 2015 · Review · PMID 26785480
- NAD(+) rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis.
Neuron · 2023 · PMID 37683629
- NAD(+) Intermediates: The Biology and Therapeutic Potential of NMN and NR.
Cell metabolism · 2018 · Review · PMID 29249689
- Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.
The journals of gerontology. Series A, Biological sciences and medical sciences · 2023 · Review · PMID 37068054
FAQ
Questions about NAD+
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in cells that is central to converting nutrients into usable energy. Research examines its role in redox reactions, mitochondrial output, and repair pathways associated with biological aging. It is categorized as a longevity research compound, and reviews have discussed how NAD+ levels relate to aging, metabolism, and neurodegeneration.
NAD+ acts as an electron carrier, cycling between oxidized and reduced forms to shuttle electrons through the reactions that generate cellular energy. It is also a required substrate consumed by sirtuin enzymes, which are studied for metabolic regulation, mitochondrial upkeep, and stress response. This links NAD+ availability to cellular maintenance signaling, a relationship examined in reviews of NAD+ and sirtuins in aging and disease.
Research has studied NAD+ in the context of aging, metabolism, and neurodegeneration, largely through reviews and animal models. One animal study reported that NAD+ addressed aging-induced blood-brain barrier damage via the CX43-PARP1 axis. Human trials have mostly examined NAD+-boosting precursors, including a randomized trial of NMN in healthy middle-aged adults and one reporting increased muscle insulin sensitivity in prediabetic women.
Human safety data for subcutaneous NAD+ are limited, and adverse events for NAD+ itself are not summarized in the cited studies. Much of the available human safety information concerns the precursor NMN, whose safety has been reviewed across clinical trials. At least one review has also discussed both promises and safety concerns of NMN as an anti-aging product, so findings should be interpreted cautiously.
Research protocols have used 50–200 mg per administration, 3 times per week in the morning, delivered subcutaneously, with a continuous reported cycle. These figures describe what protocols have used and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference. Related human trials of NAD+ precursors such as NMN have used oral supplementation rather than direct NAD+ administration.
Ask about NAD+
Plain answers from our library: the science, the studied ranges and our products. It can be wrong, and it does not give medical advice.
AI answers can be wrong. Research use only.
Compare
Related comparisons
- NAD+ vs MOTS-cNAD+ and MOTS-c are both studied in longevity and metabolic research, but they differ in kind. NAD+ is a coenzyme that acts as an electron carrier in the reactions releasing energy from nutrients and serves as a required substrate for sirtuin enzymes. MOTS-c is a peptide encoded in mitochondrial DNA, described as translocating to the nucleus under metabolic stress, where it is studied for effects on metabolic genes largely via AMPK-associated pathways. NAD+ has been studied for cellular energy metabolism, sirtuin activity, and aging-related metabolic decline and neurodegeneration. MOTS-c has been studied mainly in animal and cell models of obesity, insulin resistance, bone metabolism, and lung injury. Human safety data are limited for both.